Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
 

Diabetes Update Program 2018


Diabetes Update Program
February 3, 2018
MUSC Bioengineering Building Auditorium
 
To register online, visit www.musc.edu/strategies/onlineregistration!  To register via check, please see the instructions in the attached flyer.
 
Learning Objectives for Pharmacists
 
Pathogenesis of DM---Katherine A. Lewis, MD, MSCR
  1. Review the pathogenesis of diabetes mellitus (DM).
  2. Describe and differentiate Type 1 and Type 2 diabetes.
  3. State diagnostic criteria.
DKA, HHS, Hypoglycemia---Katherine A. Lewis, MD, MSCR
  1. Discuss three acute complications of diabetes with treatment modalities.
  2. Summarize clinical findings, management and complications of DKA, HHS and hypoglycemia.
  3. Recognize the similarities and differences between DKA and HHS.
  4. Define prevention strategies for hypoglycemia in diabetes.
Diabetes in Children and Adolescents---Sharon Schwarz, APRN, MSN, CDE
  1. Discuss principles of DM Management in children and adolescents.
  2. State goals for HgA1C and blood glucose levels for children/teens with diabetes.
  3. State common emergencies related to children/teens with diabetes.
  4. Recognize developmental stages of children/teens as they related to managing diabetes.
  5. Review types of insulin pumps and continuous glucose monitoring utilized for glucose management with children and teens.
Glucose Monitors, Pumps & Sensors---Jennifer Z. McCrudden, MSN, FNP-C, CDE
  1. Identify principles of glucose monitoring.
  2. Discuss self-management blood glucose monitoring (SMBG) and continuous glucose monitoring (CGM).
  3. Discuss insulin pumps and integration of continuous glucose monitoring.
Pregnancy and Diabetes---Christopher G. Goodier, MD
  1. Discuss principles of diabetes management in pregnancy.
  2. Describe the metabolism of normal pregnancy and the alterations which occur in overt and gestational diabetes.
  3. Describe the diagnostic criteria and screening recommended by the ADA.
  4. Describe potential maternal and fetal complications.
  5. Summarize treatment options in GDM.
Medical Nutrition Therapy for Diabetes--- Courtney Morrissey, MS, RD, LD
  1. Analyze Medical Nutrition Therapy (MNT) as an approach to the non-pharmacological management of DM.
  2. Review recommendations for Medical Nutrition Therapy from the American Diabetes Association and Academy of Nutrition and Dietetics.
  3. Review strategies to aid patients with diabetes in controlling their BG levels with diet.
  4. Recall tips to help create a realistic and individualized nutrition plan for patients.
  5. Review the current trends in nutrition affecting counseling.
Pharmacologic Approaches for Diabetes---Part 1 & Part 2-Wayne Weart, PharmD, BCPS, FASHP, FAPhA
  1. Apply the pharmacological treatment of diabetes to case studies.
  2. Describe the current 2018 ADA Standards of Medical Care for the diagnosis and management of diabetes mellitus.
  3. Review the data on the newer FDA approved medications for the management of Type 2 diabetes.
  4. Discuss the appropriate use of evidence-based and cost effective therapies in the management of patients with Type 2 DM.

Date: Feb 3, 2018 07:30 AM - 04:00 PM

Fee

$0.00

CE Hours

7.00

CE Units

0.700

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists

Accreditation(s)

Accreditation Council for Pharmacy Education
The University of South Carolina College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Co-Sponsor(s)

Diabetes Initiative of South Carolina

Requirements for CE Credit

Participants must sign in upon arrival and have attendance verified.  Completion of the online program via this site within 30 days of the live program will ensure correct transmission of credit to the NABP CPE Monitor.  The NABP CPE Monitor will automatically reject any credit claimed greater than 60 days after completion of the live program.
 
To claim credit for this activity, participants must complete an online program evaluation and must update their accounts to properly reflect their month and day of birth and their correct NABP E-Id.  Registration with a proper disclosure of your NABP E-Id is a requirement for receiving Continuing Pharmacy Education.  To register with or look up your NABP E-Id, please click on the CPE Monitor logo below to be directed to their site.  Failure to follow this process within the required timeframe will result in loss of credit.  If you would like a paper statement of credit, you may print an individual statement or a transcript from your NABP e-profile.   
                                 

 

 

 

 

At the completion of this activity, the participant will be able to:
  1. Review the pathogenesis of diabetes mellitus (DM).
  2. Describe and differentiate Type 1 and Type 2 diabetes.
  3. State diagnostic criteria.
  4. Discuss three acute complications of diabetes with treatment modalities
  5. Summarize clinical findings, management and complications of DKA, HHS and hypoglycemia
  6. Recognize the similarities and differences between DKA and HHS
  7. Define prevention strategies for hypoglycemia in diabetes
  8. Discuss principles of DM Management in children and adolescents.
  9. State goals for HgA1C and blood glucose levels for children/teens with diabetes
  10. State common emergencies related to children/teens with diabetes
  11. Recognize developmental stages of children/teens as they related to managing diabetes
  12. Review types of insulin pumps and continuous glucose monitoring utilized for glucose management with children and teens.
  13. Identify principles of glucose monitoring.
  14. Discuss self-management blood glucose monitoring (SMBG) and continuous glucose monitoring (CGM)
  15. Discuss insulin pumps and integration of continuous glucose monitoring.
  16. Discuss principles of diabetes management in pregnancy.
  17. Describe the metabolism of normal pregnancy and the alterations which occur in overt and gestational diabetes.
  18. Describe the diagnostic criteria and screening recommended by the ADA.
  19. Describe potential maternal and fetal complications.
  20. Summarize treatment options in GDM.
  21. Analyze Medical Nutrition Therapy (MNT) as an approach to the non-pharmacological management of DM.
  22. Review recommendations for Medical Nutrition Therapy from the American Diabetes Association and Academy of Nutrition and Dietetics
  23. Review strategies to aid patients with diabetes in controlling their BG levels with diet
  24. Recall tips to help create a realistic and individualized nutrition plan for patients
  25. Review the current trends in nutrition affecting counseling
  26. Apply the pharmacological treatment of diabetes to case studies.
  27. Describe the current 2015 ADA Standards of Medical Care for the diagnosis and management of diabetes mellitus
  28. Review the data on the newer FDA approved medications for the management of Type 2 diabetes
  29. Discuss the appropriate use of evidence-based and cost effective therapies in the management of patients with Type 2 DM.

Speaker(s)/Author(s)

C. Wayne Weart, PharmD, FASHP, FAPhA
Professor Emeritus Department of Clinical Pharmacy and Outcome Sciences and Professor of Family Medicine, MUSC College of Pharmacy

Christopher Goodier, MD
Assistant Professor of Medicine, Department of Obstetrics/Gynecology, Medical University of South Carolina

Courtney Morrissey, MS, RD, LD
Clinical Dietitian

Jennifer McCrudden, MSN, FNP-C, CDE
Diabetes Nurse Practitioner, Division of Endocrinology, Diabetes and Metabolic Diseases, Medical University of South Carolina

Katherine Lewis, MD, MSCR
Assistant Professor of Medicine, Division of Endocrinology, Diabetes and Metabolic Diseases, Medical University of South Carolina

Sharon Schwarz, APRN, MSN, CDE
Diabetes Educator; Instructor, Trident Technical College

Activity Number

0062-9999-18-011-L01-P
Date: 02/03/18
Time: 07:30 AM - 04:00 PM

CE Hours

7.00